Tevogen Bio Inc.

NASDAQ: TVGN · Real-Time Price · USD
0.94
-0.01 (-0.88%)
At close: Aug 18, 2025, 10:46 AM

Tevogen Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.73M -60.48M -22.04K -15.6M
Depreciation & Amortization
403.58K 378.36K 230.82K 9.38K
Stock-Based Compensation
40.76M n/a 4.58M 582.41
Other Working Capital
-1.69M -638.75K 566.61K -571.78K
Other Non-Cash Items
-39.43M 52.75K -10.17M 10.98M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-5.49K 897.62K 737.69K -1.25M
Operating Cash Flow
-12M -1.38M -215.4K -5.27M
Capital Expenditures
n/a -133K -479.04K -109.73K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -351.9M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 479.04K n/a
Investing Cash Flow
n/a -133K -479.04 -109.73K
Debt Repayment
1M 4M 7.5K 12.5M
Common Stock Repurchased
n/a -342.98M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
229.33K 342.86M n/a n/a
Financial Cash Flow
12.23M 3.87M 7.5K 12.5M
Net Cash Flow
230.6K -4.43M -215.4K 7.12M
Free Cash Flow
-12M -8.3M -694.44K -5.38M